Acro Biomedical (ACBM) Shares Outstanding (2015 - 2026)

Acro Biomedical has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $60.0 million in Q2 2023.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $60.0 million in Q2 2023; TTM through Jun 2023 was $60.0 million, a 0.0% change from a year earlier, with the FY2019 full-year figure at $47.8 million, changed N/A from the prior year.
• Shares Outstanding (Entity) was $60.0 million for Q2 2023 at Acro Biomedical, roughly flat from $60.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $60.0 million in Q3 2021, with the low at $47.8 million in Q1 2019.
• Average Shares Outstanding (Entity) over 5 years is $53.1 million, with a median of $47.8 million recorded in 2019.
• The sharpest annual moves came in 2019 and 2021: Shares Outstanding (Entity) changed 0.0% in 2019, then rose 25.72% in 2021.
• Over 5 years, Shares Outstanding (Entity) stood at $47.8 million in 2019, then changed by 0.0% to $47.8 million in 2020, then grew by 25.72% to $60.0 million in 2021, then changed by 0.0% to $60.0 million in 2022, then changed by 0.0% to $60.0 million in 2023.
• The last three Shares Outstanding (Entity) figures came in at $60.0 million (Q2 2023), $60.0 million (Q1 2023), and $60.0 million (Q3 2022), per Business Quant data.